demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID 19 hospitalizedCOVID-19 mild to moderate
ivermectin Gonzalez ... Shahbaznejad RIVET-COV ... Abd-Elsalam Ahmed Krolewiecki Chachar I-TECH ... Chaccour Bukhari Mayer Kirti Babalola
ivermectin plus doxycycline Hashim A NCT04523831 ...

0 studies excluded by filtering options 1